Cambridge Investment Research Advisors, Inc. Baxter International Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$27.1 Billion
Q2 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 29,651 shares of BAX stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,651

Previous 32,714 9.36%

Holding current value

$1.17 Million

Previous $1.4 Million 29.04%

% of portfolio

0.0%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$32.87 - $43.55 $100,680 - $133,393	-3,063 Reduced 9.36%	29,651 $992,000
Q1 2024 Apr 24, 2024	SELL	$37.88 - $43.77 $126,594 - $146,279	-3,342 Reduced 9.27%	32,714 $1.4 Million
Q4 2023 Feb 09, 2024	SELL	$31.71 - $38.95 $126,903 - $155,877	-4,002 Reduced 9.99%	36,056 $1.39 Million
Q3 2023 Oct 24, 2023	BUY	$37.32 - $49.29 $190,145 - $251,132	5,095 Added 14.57%	40,058 $1.51 Million
Q2 2023 Jul 13, 2023	BUY	$39.98 - $47.68 $60,449 - $72,092	1,512 Added 4.52%	34,963 $1.59 Million
Q1 2023 May 11, 2023	BUY	$37.58 - $52.57 $85,231 - $119,228	2,268 Added 7.27%	33,451 $1.36 Million
Q4 2022 Feb 08, 2023	SELL	$49.7 - $57.71 $8,598 - $9,983	-173 Reduced 0.55%	31,183 $1.59 Million
Q3 2022 Oct 17, 2022	BUY	$53.86 - $66.8 $3,016 - $3,740	56 Added 0.18%	31,356 $1.69 Million
Q2 2022 Jul 13, 2022	BUY	$63.83 - $80.0 $110,425 - $138,400	1,730 Added 5.85%	31,300 $2.01 Million
Q1 2022 May 12, 2022	SELL	$76.85 - $89.45 $384,634 - $447,697	-5,005 Reduced 14.48%	29,570 $2.29 Million
Q4 2021 Feb 03, 2022	BUY	$74.57 - $87.19 $454,056 - $530,899	6,089 Added 21.38%	34,575 $2.97 Million
Q3 2021 Nov 02, 2021	SELL	$73.77 - $83.61 $124,449 - $141,050	-1,687 Reduced 5.59%	28,486 $2.29 Million
Q2 2021 Aug 10, 2021	SELL	$80.5 - $88.01 $45,160 - $49,373	-561 Reduced 1.83%	30,173 $2.43 Million
Q1 2021 May 07, 2021	BUY	$76.38 - $86.03 $546,269 - $615,286	7,152 Added 30.33%	30,734 $2.59 Million
Q4 2020 Feb 04, 2021	BUY	$75.39 - $82.36 $3,467 - $3,788	46 Added 0.2%	23,582 $1.89 Million
Q3 2020 Oct 29, 2020	SELL	$78.33 - $90.73 $12,376 - $14,335	-158 Reduced 0.67%	23,536 $1.89 Million
Q2 2020 Jul 27, 2020	BUY	$78.66 - $94.14 $73,075 - $87,456	929 Added 4.08%	23,694 $2.04 Million
Q1 2020 May 08, 2020	SELL	$71.57 - $93.3 $104,062 - $135,658	-1,454 Reduced 6.0%	22,765 $1.85 Million
Q4 2019 Feb 04, 2020	SELL	$76.7 - $88.45 $20,785 - $23,969	-271 Reduced 1.11%	24,219 $2.03 Million
Q3 2019 Nov 06, 2019	BUY	$81.4 - $89.78 $30,687 - $33,847	377 Added 1.56%	24,490 $2.14 Million
Q3 2019 Oct 28, 2019	SELL	$81.4 - $89.78 $79,365 - $87,535	-975 Reduced 3.89%	24,113 $2.11 Million
Q2 2019 Aug 15, 2019	SELL	$73.44 - $82.41 $18,066 - $20,272	-246 Reduced 0.97%	25,088 $0
Q1 2019 May 08, 2019	BUY	$64.48 - $81.31 $130,572 - $164,652	2,025 Added 8.69%	25,334 $0
Q4 2018 Feb 05, 2019	SELL	$61.45 - $77.8 $80,069 - $101,373	-1,303 Reduced 5.29%	23,309 $1.53 Million
Q3 2018 Nov 02, 2018	BUY	$70.71 - $77.75 $78,205 - $85,991	1,106 Added 4.71%	24,612 $0
Q2 2018 Aug 10, 2018	BUY	$63.43 - $75.41 $35,457 - $42,154	559 Added 2.44%	23,506 $0
Q1 2018 May 09, 2018	SELL	$62.56 - $72.26 $13,387 - $15,463	-214 Reduced 0.92%	22,947 $0
Q4 2017 Feb 22, 2018	SELL	$61.45 - $66.05 $557,412 - $599,139	-9,071 Reduced 28.14%	23,161 $0
Q3 2017 Nov 07, 2017	SELL	$59.5 - $64.61 $63,189 - $68,615	-1,062 Reduced 3.19%	32,232 $2.02 Million
Q2 2017 Aug 08, 2017	BUY	N/A	33,294	33,294 $2.02 Million

Others Institutions Holding BAX

# of Institutions

981

Shares Held

446M

Call Options Held

2.22M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Baxter International Inc Transaction History